Clinical trial
VISANNE OS/Treatment of Endometriosis With Dienogest in the Real World Clinical Practice
NCT04495855 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VISANNE OS/Treatment of Endometriosis With Dienogest in the Real World Clinical Practice
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 28, 2020
- Completion date
- December 23, 2022
- Enrollment
- 968 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.